The composition of the superfusing Tyrode solution was therefore kept constant with regards to other components that are changed in vivo in the metabolic syndrome (e.g. the concentration of glucose, fatty acid and insulin) and further studies are required to elucidate the interacting effects of multiple changes of the extracellular environment. The gene discussed is INS; the disease is metabolic syndrome.